EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
<h4>Purpose</h4>Extracellular matrix metalloproteinase inducer (EMMPRIN) has been reported to play crucial roles, including in angiogenesis, in several carcinomas. However, the correlation between EMMPRIN levels and angiogenesis expression profile has not been reported, and the role of E...
Guardado en:
Autores principales: | Mototaka Sato, Yasutomo Nakai, Wataru Nakata, Takahiro Yoshida, Koji Hatano, Atsunari Kawashima, Kazutoshi Fujita, Motohide Uemura, Hitoshi Takayama, Norio Nonomura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/58d32f8a4b1a491a86c5c6f79d163574 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Decreased renal function increases the nighttime urine volume rate by carryover of salt excretion to the nighttime
por: Kentaro Takezawa, et al.
Publicado: (2021) -
Sunitinib for advanced renal cell cancer
por: Chris Coppin
Publicado: (2008) -
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
por: Hiroki Tsujinaka, et al.
Publicado: (2020) -
EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.
por: Faten Bougatef, et al.
Publicado: (2010) -
Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.
por: Stephan Ursprung, et al.
Publicado: (2021)